Novo Nordisk A/S (NVO) Insider Trading & Ownership $54.94 +0.64 (+1.18%) Closing price 03:59 PM EasternExtended Trading$54.93 -0.01 (-0.02%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock There is no recent insider trading on record for Novo Nordisk A/S, but the stock has been recently traded by U.S. Congress members, who may have more information about the industry than the general public. Get NVO Insider Trade Alerts Want to know when executives and insiders are buying or selling Novo Nordisk A/S stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Novo Nordisk A/S Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellAverage Share PriceTotal Transaction8/28/2025Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$56.12$1,001 - $15,0008/19/2025Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$54.74$15,001 - $50,0008/4/2025C. Scott FranklinU.S. Congress Member (R-FL)Buy$48.86$1,001 - $15,0008/4/2025C. Scott FranklinU.S. Congress Member (R-FL)Buy$48.86$15,001 - $50,0007/30/2025Michael T. McCaulU.S. Congress Member (R-TX)Sell$50.04$50,001 - $100,0007/10/2025Lisa C. McClainU.S. Congress Member (R-MI)Sell$71.06$1,001 - $15,0006/27/2025Michael T. McCaulU.S. Congress Member (R-TX)Sell$68.50$50,001 - $100,0006/16/2025Michael T. McCaulU.S. Congress Member (R-TX)Sell$77.02$15,001 - $50,0006/9/2025Lisa C. McClainU.S. Congress Member (R-MI)Buy$75.45$1,001 - $15,0005/8/2025Laurel M. LeeU.S. Congress Member (R-FL)Sell$64.78$1,001 - $15,0003/27/2025C. Scott FranklinU.S. Congress Member (R-FL)Buy$70.18$1,001 - $15,0003/27/2025C. Scott FranklinU.S. Congress Member (R-FL)Buy$70.18$15,001 - $50,0003/20/2025Byron DonaldsU.S. Congress Member (R-FL)Sell$78.73$1,001 - $15,0009/4/2024John JamesU.S. Congress Member (R-MI)Sell$134.50$1,001 - $15,0001/19/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$106.95$15,001 - $50,0007/12/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$38.69$100,001 - $250,0007/10/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$39.27$250,001 - $500,000 (Data available from 1/1/2013 forward) NVO Insider Trading Activity - Frequently Asked Questions What percentage of Novo Nordisk A/S stock is owned by insiders? 0.07% of Novo Nordisk A/S stock is owned by insiders. Learn more on NVO's insider holdings. Which members of congress are trading Novo Nordisk A/S? Marjorie Taylor Greene (R-GA), C. Scott Franklin (R-FL), and Lisa C. McClain (R-MI) have bought shares of Novo Nordisk A/S in the last year totaling $129,500. Michael T. McCaul (R-TX), Lisa C. McClain (R-MI), Laurel M. Lee (R-FL), and Byron Donalds (R-FL) have sold shares totaling $206,500. Novo Nordisk A/S Key ExecutivesMr. Lars Fruergaard Jorgensen (Age 58)President, CEO & Member of Management Board Compensation: $4.84MMr. Karsten Munk Knudsen (Age 53)Executive VP, CFO & Member of the Management Board Compensation: $1.92MMr. Henrik Ehlers Wulff (Age 54)Executive VP of Product Supply, Quality & IT and Member of the Management Board Compensation: $1.93MMs. Camilla Sylvest (Age 52)Executive VP of Commercial Strategy & Corporate Affairs and Member of the Management Board Compensation: $1.89MDr. Martin Holst Lange (Age 54)Executive VP of Development & Member of the Management Board Compensation: $1.83MDr. Marcus Schindler Ph.D. (Age 58)EVP of Research & Early Development, Chief Scientific Officer & Member of the Management Board Compensation: $1.83MMr. Maziar Mike Doustdar (Age 54)Executive VP of International Operations & Member of the Management Board Mr. Douglas J. Langa (Age 58)Executive VP of North America Operations & Member of Management Board Mr. Ludovic Helfgott (Age 50)Executive VP, Head of Rare Disease & Member of Management Board Ms. Tania Sabroe (Age 47)Executive VP of Global People & Organisation and Member of Management Board More Insider Trading Tools from MarketBeat Related Companies NVS Insider Ownership AZN Insider Ownership SNY Insider Ownership GSK Insider Ownership TAK Insider Ownership ARGX Insider Ownership ONC Insider Ownership INSM Insider Ownership BNTX Insider Ownership TEVA Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Sell These High-Quality Stocks: Why Investors Shouldn’tCoreWeave and Madrigal's Insider Trades Flash Bullish SignalsPalantir Insider Selling: Risk Signal or Normal Activity?Loop Industries Insiders Buy Stock, Signal Confidence in OutlookDueling Insider Moves: Heavy Buying Here, Big Selling There This page (NYSE:NVO) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Nordisk A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.